Submitted by Anonymous (not verified) on 21 November 2025 - 13:45
Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Date of authorisation: 20/02/2014, Revision: 26, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Date of authorisation: 20/02/2014, Revision: 26, Status: Authorised